Press Release Archive

02.17.2012

Pfizer And Hisun Announce Progress On Potential Joint Venture To Increase Access To High Quality Branded Generic Medicines

02.17.2012

Pfizer And Hisun Announce Progress On Potential Joint Venture To Increase Access To High Quality Branded Generic Medicines

02.14.2012

FDA Accepts Pfizer’s New Drug Application for Tafamidis Meglumine, a Novel, Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)

02.01.2012

Pfizer Issues Statement On Voluntary Recall

02.01.2012

Pfizer Announces Voluntary Nationwide Recall Of Lo/Ovral®-28 And Norgestrel/Ethinyl Estradiol Tablets Due To Possibility Of Inexact Tablet Counts Or Out Of Sequence Tablets

01.30.2012

Pfizer Reports Fourth-Quarter and Full-Year 2011 Results; Updates 2012 Financial Guidance

01.29.2012

Private and Public Partners Unite to Combat 10 Neglected Tropical Diseases by 2020

01.27.2012

U.S. Food And Drug Administration Approves Pfizer’s INLYTA® (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)

01.26.2012

Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ Chronic Myeloid Leukemia

01.25.2012

Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer’s Care

01.25.2012

KineMed announced a non-exclusive research collaboration with Pfizer for the advancement of novel approaches towards metabolic disease, in particular Type II Diabetes.

01.22.2012

MS LifeLines® Earns J.D. Power and Associates Call Center Certification for Customer Service Excellence in Providing Support Services to the MS Community